Bristol-Myers Squibb Stock Prediction and Forecast [BMY]

AI-generated source summary

The video presents a bearish outlook for Bristol-Myers Squibb (BMY). On October 2nd, 2025, the system ranked it as a sell candidate, with a score of -3.82. The stock is in a declining trend in the short term, with a potential decrease of 3.7% over the next three months. The trading levels indicate the weekly volatility is 3.51%, and a first support at $45.10 is expected. If it’s broken, further declines are anticipated. Elkins David V had a sell of 56,000 shares of common stock with par value of $0.10, Short Bartie Wendy buy of 1,235 shares, Short Bartie Wendy sell of 632 shares, Short Bartie Wendy sell of 1,235 shares and Massacesi Cristian buy of 204,691 shares. The stock expected to open up $0.540 and start trading at $46.27.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   03 Oct 2025, 03:59 UTC

   The analyst published the original source item.

2. First prediction resolved

   03 Oct 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   03 Oct 2025, 13:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 01:22 UTC

   Tahlil Plus began monitoring the extracted predictions.